EUVIMEDEUVIMED entdecken
Crossref

Silymarin Protects Against Daunorubicin‐Induced DNA Damage in an In Vivo Comet Assay

Muhammad Mustafa iD, Aiman Tariq iD, Muhammad Khisroon iD, Aiman Mehroon iD, Aaliya Saleem iD, Bushra Arshad iD

Environmental and Molecular Mutagenesis · 2026

DOI: 10.1002/em.70080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environmental and Molecular Mutagenesis, 2026. Verfasst von Muhammad Mustafa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Zoological Sciences, University of Peshawar, Peshawar, Pakistan. Hauptthemen laut MEDLINE: Daunorubicin, Silymarin, DNA Damage, Antibiotics, Antineoplastic. Die Arbeit nennt 63 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Daunorubicin is an anthracycline chemotherapy drug that is active against leukemias but has significant effects on normal cells, leading to long‐term toxicity. The flavanolignan silymarin, which is extracted from milk thistle, has well‐known antioxidant and cytoprotective effects. This study examined the protective activity of silymarin against daunorubicin‐induced primary damage to DNA in lymphocytes of rats. Adult Wistar rats were divided into four groups and administered silymarin by oral gavage and daunorubicin by a single intraperitoneal injection. Isolation of peripheral‐blood lymphocytes was followed by alkaline single‐cell gel electrophoresis (comet assay). The amount of DNA damage was determined as the percentage of DNA in the comet tail and was analyzed at the animal level using parametric and nonparametric statistics. DNA migration was extensive when treated with daunorubicin. The administration of silymarin in combination significantly reduced this damage, and it changed the profile of cellular damage from extreme to mostly moderate. There was no significant increase in DN damage in animals given silymarin. Silymarin has a clear antigenotoxic effect in vivo in the presence of daunorubicin, and it could be a useful chemoprotective adjuvant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DaunorubicinSilymarinDNA DamageAntibiotics, AntineoplasticProtective AgentsAnimalsComet AssayRats, WistarRatsMaleLymphocytesAntioxidants

Stichwörter der Autor:innen

anthracyclineschemoprotectivecomet assaycomet taildaunorubicinsilymarin

Substanzen

DaunorubicinSilymarinAntibiotics, AntineoplasticProtective AgentsAntioxidants

Autor:innen und Institutionen

  • Institute of Zoological Sciences, University of Peshawar, Peshawar, Pakistan.
  • Department of Biosciences, COMSATS University Islamabad, Islamabad, Pakistan.
  • MEDIcen Project, Pakistan Council of Scientific & Industrial Research Laboratories Complex, Peshawar, Pakistan.
  • APIs Project, Pakistan Council of Scientific & Industrial Research Laboratories, Islamabad, Pakistan.

ORCID-Profile: Muhammad Mustafa, Aiman Tariq, Muhammad Khisroon, Aiman Mehroon, Aaliya Saleem, Bushra Arshad

Zitieren

APA

Mustafa, M., Tariq, A., Khisroon, M., Mehroon, A., Saleem, A., & Arshad, B. (2026). Silymarin Protects Against Daunorubicin‐Induced DNA Damage in an In Vivo Comet Assay. Environmental and Molecular Mutagenesis. https://doi.org/10.1002/em.70080

Vancouver

Mustafa M, Tariq A, Khisroon M, Mehroon A, Saleem A, Arshad B. Silymarin Protects Against Daunorubicin‐Induced DNA Damage in an In Vivo Comet Assay. Environmental and Molecular Mutagenesis. 2026. doi:10.1002/em.70080

BibTeX
@article{Mustafa2026,
  author = {Mustafa, Muhammad and Tariq, Aiman and Khisroon, Muhammad and Mehroon, Aiman and Saleem, Aaliya and Arshad, Bushra},
  title = {Silymarin Protects Against Daunorubicin‐Induced DNA Damage in an In Vivo Comet Assay},
  journal = {Environmental and Molecular Mutagenesis},
  year = {2026},
  doi = {10.1002/em.70080}
}
Kostenlos starten →